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Abstract
Background: Mortality from breast cancer has decreased in high-
income countries, while countries with middle and low incomes as 
Brazil still have upward trend. However, large geographical variations 
among the federal units are observed in the country. The aim of 
the study was to evaluate the trend of specific mortality from breast 
cancer in women over 20 years old among different states of Brazil 
from 1996 to 2012. 
Methods and Findings: Ecological study, using linear regression 
model for temporal analysis of specific mortality coefficient from ma-
lignant neoplasm of breast. We also checked the degree of its corre-
lation with the HDI for the states of Brazil during the stated period. 
There was an increase in the specific mortality rate for malignant 
neoplasm of the breast in order of 33%, with range from 23.2 to 
30.8/100,000 inhabitants. The states with the highest human deve-
lopment HDI in 2010, showed the largest specific mortality rates of 
breast cancer. 
Conclusion: This study confirms the need for improvements in mam-
mography coverage, following radiological lesions suspected and ac-
cess to appropriate therapy.
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Introduction
Breast cancer is the second most frequent cancer in 
the world, corresponding to 22% of new cases of 
cancer each year. In middle and low-income coun-
tries it is more frequent cancer in female population, 
followed by the cervical cancer of uterus and lung 
cancer [1].
In recent decades, in the high-income countries, 
breast cancer mortality has been on decline [2]. 
However, medium and low-income countries still 
exhibit upward trends [3]. This is explained, in part, 
by the demographic changes and lifestyle, that in-
terfere with prevalence of reproductive factors such 
as breastfeeding for short periods of time, advanced 
age at first pregnancy and lower number of children 
[4, 5], inadequate food intake, obesity overweight 
and stress [5,6]. Other linked factors relate to the 
abusive consumption of alcohol, early menarche 
and late menopause [7].
In Brazil, breast cancer is the leading cause of 
mortality for neoplasia among women [8], with a 
rate of 15.8/100,000 in 2011 [8]. 
One of the main difficulties for the reduction 
of mortality for breast cancer is the diagnosis only 
in advanced stages of the disease, which compro-
mises the treatment results [9], especially in low-
income women [10]. Early detection of breast neo-
plasia is the main strategy of secondary prevention, 
fundamental for the good prognosis of disease [6, 
11, 12]. 
Socioeconomic indicators are predictors of the 
incidence, diagnosis, treatment and prognosis of 
the various types of cancer in the world [13, 14]. 
The Human Development Index (HDI) is a composite 
indicator that contains information about the life ex-
pectancy at birth, educational status and the Gross 
Domestic Product (GDP) [15]. Despite being inversely 
associated with the incidence rates of cancer in ge-
neral [14], is directly associated with the incidence 
of breast cancer [16]. Part of this relationship is ex-
plained by lifestyle and by access to early diagnosis 
of breast neoplasm [5, 16-19]. 
In developed countries, the rate of survival is hig-
her due to early detection and, probably, to access 
to treatment, compared to less developed countries 
[18, 19]. Among the countries of Latin America, 
characterized by urban poverty, which exacerbates 
social disparities, Brazil continues to present itself 
as a favorable area to study geographic patterns of 
mortality from breast cancer.
In this study, it was decided to analyze the tem-
poral tendency of malignant neoplasm of breast 
cancer in Brazil, in women older than 20 years in 
Federated units and administrative macro-regions 
for providing a national overview, in the period of 
1996 to 2012, and its correlation with the HDI in 
the year 2010.
Methods
This is an ecological study assessing the temporal 
trends of breast cancer mortality in women aged 
over 20 years in the Brazilian States and macro-
regions in the period of 1996 to 2012.
The information about the deaths was obtained 
from Mortality Information System of the Ministry 
of Health (MIS/MS) available in the database DATA-
SUS tabulated in March 2015, through the TABWIN 
software (version 3.6b). The deaths were selected 
for inclusion using the International Classification of 
Diseases (ICD-10) code for breast cancer (C50) and 
were categorized among States by place of resi-
dence (rather than by place of occurrence). Breast 
cancer-specific mortality coefficients were calcula-
ted with the use of a standardized population of 
the World Health Organization (WHO) by age group 
for the year 2010, considering the proportions of 
the female population above 20-year-old Brazilian, 
extracted from the projections of the demographic 
census in 1996 to 2012 (DATASUS-MS, 2012).
The human development of the Brazilian States 
was assessed through the Municipal Human Deve-
lopment Index (HDI-M), as specified by the United 
Nations Development Programme (UNDP) in Brazil. 
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The IDH-M retains the dimensions of the HDI, but 
uses data sources and minimum and maximum va-
lues for the Brazilian reality, allowing a better com-
parison between the States or Brazilian municipali-
ties. The IDH-M for the Brazilian States in 2010 was 
obtained from Brazilian Human Development Atlas 
in 2010 (http://www.atlasbrasil.org.br/2013/).
The temporal tendency of mortality from breast 
cancer was described through Prais-Winsten regres-
sion, having the year as exposure variable. On the 
other hand, linear regression was used to describe 
the relationship between breast cancer mortality 
and the HDI-M States in 2010.
Coropletic maps for the four years 1996-1999, 
2000-2003, 2004-2008 and 2009-2012 were drawn 
from the ranges of specific mortality coefficients of 
breast cancer mortality, incorporating the propor-
tional circle for each federated unit, following the 
linear scale from 10 deaths per 100,000 inhabitants 
with amplitude up to 50 deaths per 100,000 inha-
bitants. The data used in the study are aggregated 
and publicly available, so that it did not require the 
approval by the Ethics Committee.
Results
Temporal analysis of breast cancer mortality in Brazil 
showed an upward trend, especially after 2001, ran-
ging from 23.2 to 30.8/100,000 inhabitants from 
1996 to 2012. The increase observed was 33% in 
this period (Table 1). This increase was observed in 
all States of the Federation, noting that, for the pe-




1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012
North 8.5 8.0 10.1 9.0 9.6 8.5 10.9 10.6 11.3 11.2 13.1 11.9 14.0 12.9 12.7 15.5 15.2
Rondônia 4.0 5.0 11.2 9.1 10.6 6.6 12.7 12.1 11.5 11.1 11.7 15.9 20.1 18.3 11.1 16.7 10.3
Acre 5.4 10.5 6.4 4.9 7.9 8.7 9.6 7.3 5.1 10.3 10.0 8.1 5.0 4.1 3.7 12.4 23.0
Amazonas 11.4 11.1 14.7 11.0 12.0 9.9 8.6 11.5 10.8 9.0 12.7 11.5 14.7 12.3 14.3 16.9 21.0
Roraima 16.3 13.2 7.7 7.5 11.8 9.4 3.7 5.3 12.1 16.3 15.8 10.3 5.9 13.0 11.0 16.7 25.7
Pará 9.1 8.1 9.1 9.4 8.9 8.5 12.1 10.1 11.8 13.3 13.7 12.2 14.0 13.0 13.3 14.8 12.3
Amapá 0.0 3.3 4.7 3.0 11.9 13.9 4.9 5.9 10.3 6.4 11.3 7.4 6.7 5.6 7.3 14.3 10.9
Tocantins 7.2 3.5 7.9 6.6 5.6 5.5 13.2 14.4 12.7 6.8 13.7 10.5 14.3 15.5 15.4 16.3 16.8
Northeast 12.1 12.8 14.0 13.1 13.8 13.9 15.2 16.0 17.0 18.8 21.8 20.0 21.5 21.4 22.8 23.1 24.0
Maranhão 4.4 4.1 6.1 4.4 5.7 5.1 5.4 6.0 5.4 11.0 11.4 8.2 11.2 12.6 12.9 13.8 13.6
 Piauí 6.2 5.7 5.5 7.8 9.1 10.6 12.3 11.3 14.3 15.8 17.1 16.5 20.2 19.8 19.2 23.1 23.5
Ceará 14.0 16.3 17.8 18.7 17.0 16.8 20.3 20.4 21.4 21.5 25.7 23.9 25.7 23.8 26.5 26.3 26.0
Rio G. Norte 16.7 15.4 14.6 11.2 14.0 11.4 14.3 17.3 21.5 16.8 21.7 20.4 23.8 23.0 23.1 21.7 26.8
Paraíba 7.5 8.7 11.5 8.1 7.9 11.2 12.4 12.9 16.8 21.7 21.5 22.9 22.4 23.4 24.1 22.9 24.9
Pernambuco 20.0 20.8 21.6 20.2 20.2 20.3 22.3 23.9 25.2 26.5 32.0 25.9 28.1 27.5 29.8 28.0 28.6
Alagoas 5.7 10.9 9.3 10.1 11.8 12.7 10.2 11.3 11.3 19.0 16.5 17.4 17.4 19.4 20.3 21.2 22.8
Sergipe 11.3 8.4 13.5 13.6 14.9 17.8 15.0 19.3 18.7 20.0 20.4 23.4 24.4 28.9 24.0 26.8 32.4
Bahia 11.7 12.1 13.3 12.1 13.8 13.0 14.0 14.4 14.3 15.2 19.4 18.5 18.9 18.6 20.8 22.3 22.3
Southeast 31.2 32.6 32.6 33.4 30.8 32.1 32.2 32.6 34.0 33.7 33.8 32.3 34.0 33.3 34.5 35.3 36.0
Minas Gerais 19.8 21.2 20.6 20.2 18.1 19.6 19.5 22.1 23.5 22.2 24.3 22.5 24.3 23.7 25.3 28.1 28.3
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riod 2009-2012, all States had mortality rates above 
20 deaths/100,000 inhabitants (Figure 1). 
The macro-regions South and Southeast presen-
ted coefficients higher than national values for the 
period of 1996 to 2012 (Figure 2).
In this period the yearly increase in the morta-
lity rate was 0,41 (IC95% 0,33-0,50). The macro-
regions with highest increases were the Northeast 
with 0.79 (IC95% 0.66-0.92) and the Central-West 
with 0.56 (IC95% 0.43-0.69), followed by the South 
and North with 0.47 (IC95% 0.30-0.64) and 0.43 
(IC95% 0.36-0.49), respectively, and the Southeast 
with 0.21 (IC95% 0.11-0.31 (Figure 2).
In 2010, the states with the highest mortality 
rates were Rio de Janeiro (44.3/100,000 inhab.) 
and Rio Grande do Sul (43.8/100,000 inhabitants.), 
in the Southeast and South Regions, respectively. 
In the North the highest rates were in the sta-
tes of Amazonas (14.3/100,000 inhab.) and Pará 
(13.3/100,000 inhabitants.); in the Northeast, the 
states of Pernambuco (29.8/100,000 inhab.) and 
Ceará (26.5/100,000 inhabitants.); in the Central-
States
Year
1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012
Espírito Santo 17.6 21.8 15.1 17.0 17.0 20.0 23.9 26.1 27.3 25.6 25.3 22.6 27.1 25.4 28.0 30.7 30.7
Rio de Janeiro 40.6 43.5 43.5 43.9 40.8 42.7 41.6 41.4 44.2 42.7 44.3 45.8 46.7 46.7 45.4 44.5 46.7
São Paulo 33.6 34.0 35.0 36.4 33.5 34.5 34.8 34.3 35.1 36.0 34.6 32.2 33.9 32.9 34.8 35.3 35.6
South 27.5 29.5 32.1 31.6 30.8 31.1 32.6 32.6 33.0 33.2 34.2 32.2 32.6 33.8 35.7 37.3 37.0
Paraná 22.6 24.6 24.2 26.0 25.2 27.0 29.0 26.5 27.6 29.3 29.5 27.6 28.8 29.8 30.3 33.1 33.7
Santa Catarina 21.3 24.5 26.3 24.2 25.3 23.6 25.8 25.7 24.2 26.8 26.1 25.6 25.4 28.7 30.1 32.1 33.2
Rio Gr. do Sul 34.7 36.2 41.6 39.9 38.4 38.6 39.1 41.3 42.1 39.8 42.5 39.8 39.9 40.3 43.8 44.1 42.3
Central-West 14.2 17.9 18.4 19.7 18.1 18.5 17.5 21.1 19.9 20.8 23.3 19.5 22.3 23.1 24.0 25.0 26.8
Mato G. do Sul 12.0 17.0 18.1 26.1 18.6 21.9 20.9 31.3 24.3 28.2 30.2 18.7 32.8 27.2 29.9 26.8 28.4
Mato Grosso 11.3 13.6 11.6 15.3 13.9 14.2 13.6 11.0 13.7 14.4 17.0 17.6 18.8 18.3 20.3 20.7 25.4
Goiás 12.8 17.1 18.6 16.8 16.1 16.3 16.2 18.5 18.9 18.6 19.8 18.1 18.7 22.7 22.2 25.2 25.3
Dist. Federal 22.4 25.0 25.4 24.8 26.5 25.0 21.6 28.3 24.6 25.5 31.3 25.1 24.8 25.3 26.5 27.7 30.2
Brazil 23.2 24.5 25.4 25.4 24.2 24.8 25.5 26.1 27.0 27.4 28.7 26.8 28.3 28.1 29.3 30.2 30.8
Figure 1:  Coefficient of specific mortality by 
breast cancer accumulated quadrennial 
in women over 20 years in de Brazilian 
states, Brazil, 1996-2012.
Figure 2:  Mortality rate for breast câncer in wo-
men over 20 years by Brazilian regions, 
Brazil; 1996-2012.
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West Region, in Mato Grasso do Sul (29.9/100,000 
inhab.) and the Federal District (26.5/100,000 in-
habitants.). These states exceeded the respective 
regions coefficients (Table 1).
Regarding the HDI-M, during the year 2010, the 
States with the highest HDI were those with higher 
mortality from breast cancer. Each 0.1 additional 
point HDI-M was associated with an increase in 11.4 
(95% CI 4.4 to 18.3) in the standardized coefficient 
of breast cancer mortality, explaining 31.4% of its 
variability between States. The States of the North 
Region had breast cancer mortality rate substantially 
lower than that of the Northeast States, although 
they had a similar HDI-M (Figure 3).
Discussion
The study showed increasing breast cancer mortality 
behavior in Brazil in 1996 to 2012.
The findings confirm the upward trend of the 
mortality from malignant neoplasm of the breast in 
agreement with other studies [20, 21]. Zapponi and 
Melo [20] conducted a study on the mortality of 
women for breast cancer in the period from 2003 to 
2007, with the use of the database and checked a 
higher concentration of deaths for this specific cause 
in the South and Southeast regions, with emphasis 
to Rio de Janeiro, São Paulo and Rio Grande do Sul. 
In this study, the highest concentration of deaths 
among married women and race/ethnicity white. In 
the Southeast have observed an increase in the rate 
of the order of 12%, 6% and 22% for São Paulo, 
Rio de Janeiro and Minas Gerais, respectively. Giria-
nelli et al. [21], analyzing data aggregated from 30 
years (1980-2010) breast cancer mortality, observed 
tendencies of increasing mortality from breast can-
cer in the whole period in the five regions of the 
country. However, perceived tendency of decline of 
the coefficients in the capitals from the late 1990 
[21].
Considering the Brazilian context, in the city of 
Aracajú it was found that there was a positive co-
rrelation between breast cancer incidence and level 
of income of the area [22]. In the period from 1996 
to 2006, the standardized incidence of breast cancer 
has increased over the years, especially for women 
45 to 64 years of age. On the other hand, mortality 
only increased between 55 and 64 years of age [22]. 
In addition, there was an increase in breast cancer 
mortality in the municipality of Juiz de Fora, Minas 
Gerais, in the period from 1980 to 2006, where 
female with the disease showed more than 81% 
survival in five years. These data suggest increased 
incidence of the disease similar to that observed in 
most studies conducted in Brazil [23].
The higher chances for breast cancer mortality oc-
curred in women over 60 years and with low level of 
schooling in the study conducted in the municipality 
of Maringá, Paraná, which is statistically significant 
association [24]. This study also showed highest con-
centration of deaths among married women and 
race/ethnicity white.
The effect of the trace in reducing breast cancer 
mortality in Brazil is less than what happens with 
cervical cancer [21]. A set of factors has pointed to a 
low impact tracking measures in breast cancer mor-
Figure 3:  Realationship between the Municipal 
Human Development Index (HDI-M) 
and the standardized coeficiente of 
specific mortality from breast câncer 
among aged 20 years or older in Brazi-
lian states in 2010.
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tality in Brazil: the low mammography coverage, in-
adequate tracking of suspicious radiological findings 
and the limited access to surgical treatment [19]. 
Azevedo e Silva et al. [19], analyzing the number 
of biopsies compared to the number of cases that 
would require follow-up to diagnostic clarification, 
concluded that only 27% of women between 50 
and 59 years with mammograms with BI-RADS 4 
and 5 performed biopsy and 63% of those with 
60-69 years.
In this study, which lasted until 2012, our units of 
note were the States and analysis of the data shows 
an increase in the specific coefficient of mortality 
from breast cancer in all Brazilian regions and Fe-
deral District (Figure 2). The South and Southeast 
regions continued to show the highest coefficient of 
specific mortality for breast cancer, and the States 
of Rio Grande do Sul (43.8/100,000 inhab.) and Rio 
de Janeiro (45.4/100,000 HAB.) presented higher 
coefficients of the values of the respective regions 
(Table 1).
In Brazil, has taken place the logic of combating 
disease from the degree of economic development 
in South and Southeastern regions have the hig-
hest rates of breast cancer and are the ones that 
guarantee access to examinations and treatments 
considered of high complexity [21].
Azevedo e Silva noted that in South and Southeast 
regions there is a higher concentration of accredi-
ted services to SUS (national health system) in che-
motherapy and radiotherapy. Noted that only in the 
State of Rio de Janeiro, 44% of the cases of breast 
cancer were diagnosed in advanced stage [19].
In the study conducted by Azevedo e Silva et al. 
[19], the authors argued that the North, Northeast 
and Central-West, as well as less developed, have 
younger populations and showed smaller mortality 
rates, even after standardizing for age. Also, found 
an almost total absence of accredited services to 
SUS (national health system) in chemotherapy and 
radiation therapy in the North region, which can 
affect the prognosis of women affected by the di-
sease outside the major centers of the country [19].
Studies show the variation in the occurrence of 
breast cancer among the countries according to 
the degree of socio-economic development. The 
high-income countries boast much higher rates to 
low and medium-income [16-19]. However, in the 
richest countries the rate of survival is higher becau-
se breast cancer is detected early and women have 
more access to treatment, what does not happens 
in other emerging and poor countries [18, 19].
Our study showed positive correlation between 
breast cancer mortality and the HDI in all macro-
regions and for Brazil as a whole. The apparent con-
tradiction may be because the indicator of develo-
pment are covered by the socioeconomic compo-
nents of education and health services availability. 
Furthermore, this Brazilian pattern could be showing 
some demographic, social, nutritional, epidemiolo-
gical and cultural characteristics of each Region. 
In high-income countries, an observed decrease 
in a breast neoplasm mortality is attributed to ac-
cess to diagnosis and treatment by employing new 
technologies such as endocrine therapy, in addition 
to increased social interest in the theme for breast 
cancer prevention [5-27], in the Brazilian scenario, 
the divergence, in the extent of coverage achieved 
was not sufficient to influence the reduction of 
mortality coefficient.
It is well established that breast cancer survival 
varies according to socioeconomic status and region 
of residence and that the delay in diagnosis may re-
duce survival. In the study conducted by Mclaughlin 
et al. [10], the waiting time for initiation of treatment 
was associated with increased risk of 85% in death 
among low-income women in North Carolina [10]. 
The clinical stage of disease at diagnosis is a prog-
nostic factor key [28].
In the study by Montella et al. [29], the diagnos-
tic phase depended on subjective variables, such as 
the patient’s age, level of education, income and 
residence, as well as the specialization of the doctor 
and the dissemination of mammography exams as a 
preventive practice. According to these authors, the 
survival rate of breast cancer is probably an expres-
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sion of complex and varied components connected 
to the characteristics of the patients (for example, 
premenopausal or postmenopausal), the stage of 
the tumor, the location of the lesion, the conscious-
ness and attention of primary care caregiver, the ful-
fillment of a trace, the competence of the medical 
professionals involved in the treatment of patients 
(for example , radiologist, surgeon) and in public 
hospitals, the waiting list for admission of people 
diagnosed with breast cancer [29].
In the study by Bouchardy et al. [30], when com-
paring patients of various social classes, those of 
low social class, showed an increased risk of dying 
as a result of breast cancer (HR 2.4, 95% CI: 1.6 
-3.5), even after adjusting for conservative surgery, 
radiotherapy, chemotherapy and lymph involvement 
(HR 1.8 , IC 95%: 1.2 -2.6).
In Europe, international or regional differences in 
survival could be at least partly attributable to cultu-
ral differences which influence the phase when the 
disease is diagnosed, as well as to the different ways 
in which national health systems are organized. 
Following various measures that have been intro-
duced for prioritization of early diagnosis and imme-
diate and universal access to ideal treatment [28], 
Europe has shown a progressive reduction in the 
number of patients with advanced breast cancer at 
diagnosis [29]. However, Gatta et al. [26], point to 
a linear correlation (0.8) between health spending 
and access to diagnosis with 5-year survival among 
breast cancer in the European countries.
Thomson et al. [31], in a study conducted in Scot-
land, concluded that the survival of poor women 
with breast cancer was 10% lower than the rich, 
and the difference of estrogen receptor status only 
explained part of that difference.
Between women from all over Norway, breast 
cancer mortality is weakly associated with educa-
tion, with lower mortality among women with less 
schooling. This difference did not change between 
the 1970s and 1990s [32].
In the United States, disparities in breast cancer 
mortality are evident by State, socioeconomic sta-
tus and race/ethnicity. Although they have noticed 
significant decreases in the same over the past ten 
years, in 36 States and the District of Columbia, 
in fourteen States mortality remained unchanged. 
The decrease in mortality rates began later and was 
slower among women living in poor areas. Further 
progress in the control of breast cancer will require 
support and increase efforts to provide high-quality 
screening, diagnosis and treatment to all segments 
of the population [33].
Studies have reported a more advanced stage 
of breast cancer diagnosis in racial and ethnic sub-
groups, especially among African-American women, 
Hispanic, American Indian and women of native cul-
tures of Hawaii. Several factors may be associated 
with advanced stage at diagnosis in multicultural 
populations. These range from basic biological cha-
racteristics at the molecular and cellular level, to 
social issues, such as access to care, socioeconomic 
conditions [34] and education [35].
Schneider & d Orsi [36], in Brazil, found that the 
survival rate of breast cancer is lower in women 
under 30, with less education, and with more ad-
vanced clinical stages. The study population were 
patients enrolled in CACONs (Specialized Oncology 
treatment Center), and the analysis followed a tie-
red model [36].
We emphasize also the genetic heterogeneity of 
familial breast cancer and it is known that a signifi-
cant portion of disease is associated with inheritan-
ce of highly penetrant mutations in the BRCA 1/2 
genes [37], whose estimated prevalence for people 
with mutations in BRCA1/2 are respectively 0.11% 
and 0.12% in the general population and between 
12.8%-16% in high-risk families with three or more 
cases of breast cancer or ovary [38]. Their impact is 
influenced by exogenous exposure to carcinogenic 
factors, the type and position of the mutation and 
reproductive history, and these genes responsible 
for about 20% of the familial risk, while the other 
80% are due to a combination of the effects produ-
ced by mutations in genes known high penetrance 
[37].
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Limitation of this study stem from the fact that it 
was based on the SIM – an information system cha-
racterized by regional differences in completeness, 
coverage, and quality of information. However, even 
though the calculations may include a small number 
of incorrectly defined death causes, the system used 
contains the best data available in Brazil.
Contributions of this study is the analysis of breast 
cancer-specific mortality by the year 2012, as well as 
its analysis by States, which allowed us to observe 
the growth of this coefficient in all States of Brazil, 
even though recent study point to a trend of de-
cline of this coefficient in the capitals from the late 
1990 [21].
This study confirms the need for improvements 
in mammography coverage, following radiological 
lesions suspected and access to appropriate therapy.
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